Navigation Links
Producing Vaccines from genetically modified crops

The consortium, called Pharma-Planta, wants to produce vaccines and other treatments for major //diseases, such as HIV/Aids, rabies and TB and they hope to start clinical trials by the year 2009. The project's aim is to focus on areas that will be of greatest benefit to developing nations where they feel that access to most vaccines is very poor at the same time keeping in mind that human health and the environment are protected.

The first product, possibly grown in maize, is likely to be an antibody that can be used to block HIV transmission and it has been decided to incorporate it into a microbicidal cream that could be used in the vagina. The second product will probably to be a post-bite vaccine for rabies, which is still a significant killer in Africa and southeast Asia.

Researchers at Pharma –Planta say that the plants will be grown in pharmaceutical production units on dedicated land , isolated from food crops. Thirty-nine labs in 11 European countries will work together, with input from researchers in South Africa, where HIV/Aids is a major public health issue. Scientific co-ordinators at Pharma –Planta say many commercial companies have withdrawn from vaccine development and production because of low economic returns ,however they say that Pharma-Planta hopes the technology it will develop over the course of its initial five years of funding will eventually boost the global supply of treatments.

Current methods used include genetic modification of human cells and microorganisms such as bacteria. These techniques are labour intensive, expensive and often only produce relatively small amounts of pharmaceuticals. Researchers at Pharma – Planta say that plants are inexpensive to grow as well as to engineer them to contain a gene for a pharmaceutical product and most importantly they could produce large quantities of drugs or vaccines at low cost. The project has yet to decide which plants to use but some of the plants mos t likely to be used include tobacco, maize, potatoes and tomatoes. Although Pharma- Planta claims to maintain and follow the ideal conditions and procedures for their project others are of the opinion that Pharma- Planta’s research could have widespread negative impacts and also suggest that a clear set of criteria must be established to ensure that human health and the environment are protected

'"/>




Related medicine news :

1. A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells
2. New Technique Developed By Scientists For Producing Stem Cells without Damaging Embryos
3. Producing More Drugs For Lethal Diseases Is Not The Answer
4. A Combined Research for Producing Chlamydia Vaccine Begins
5. Height of Liberation – Lesbians, No Less in Producing Babies (read Daughters
6. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
7. New Anthrax Vaccines Will Take time
8. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
9. Health and Human Services stockpiles 20 million bird flu Vaccines
10. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
11. Oral Edible vaccine for Allergy Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology: